Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
& Gottlieb, R.A
Gohil, Francesc Palau BACKGROUND Endocrine therapy (ET) with tamoxifen (TAM) or aromatase inhibitors (AI) is highly effective against hormone receptorpositive (HR-positive) early breast cancer (BC), but resistance remains a major challenge
The choice between these treatments should consider individual health objectives, potential adverse effects, and personal health history, underlining the importance of professional healthcare advice for safe and effective use.
Development of synthetic agonists of estrogen-related receptors (ERRs) based on an aniline-based pan-agonist scaffold
US$ 22.10
US$ 22.75
US$ 24.98
US$ 23.59
US$ 21.97
US$ 27.75
US$ 25.31
US$ 26.07
